Literature DB >> 25561484

Can psychedelic compounds play a part in drug dependence therapy?

Ben Sessa1, Matthew W Johnson1.   

Abstract

After a 40-year hiatus there is now a revisiting of psychedelic drug therapy throughout psychiatry, with studies examining the drugs psilocybin, ketamine, ibogaine and ayahuasca in the treatment of drug dependence. Limitations to these therapies are both clinical and legal, but the possibility of improving outcomes for patients with substance dependency imposes an obligation to research this area. Royal College of Psychiatrists.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25561484     DOI： 10.1192/bjp.bp.114.148031

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  8 in total

Review 1.  The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.

Authors:  Matthew W Johnson; Roland R Griffiths; Peter S Hendricks; Jack E Henningfield
Journal:  Neuropharmacology       Date:  2018-06-05       Impact factor: 5.250

2.  First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants.

Authors:  Ben Sessa; Chloe Sakal; Steve O'Brien; David Nutt
Journal:  BMJ Case Rep       Date:  2019-07-15

3.  Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil.

Authors:  Dimitri Daldegan-Bueno; Lucas Oliveira Maia; Carolina Marcolino Massarentti; Luís Fernando Tófoli
Journal:  Psychopharmacology (Berl)       Date:  2022-02-18       Impact factor: 4.530

4.  Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.

Authors:  Joaquim Soler; Matilde Elices; Alba Franquesa; Steven Barker; Pablo Friedlander; Amanda Feilding; Juan C Pascual; Jordi Riba
Journal:  Psychopharmacology (Berl)       Date:  2015-11-27       Impact factor: 4.530

5.  The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women.

Authors:  Elena Argento; Melissa Braschel; Zach Walsh; M Eugenia Socias; Kate Shannon
Journal:  J Psychopharmacol       Date:  2018-09-26       Impact factor: 4.153

6.  Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.

Authors:  K P C Kuypers; J Riba; M de la Fuente Revenga; S Barker; E L Theunissen; J G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2016-07-19       Impact factor: 4.530

7.  Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting.

Authors:  Elena Argento; Steffanie A Strathdee; Kenneth Tupper; Melissa Braschel; Evan Wood; Kate Shannon
Journal:  BMJ Open       Date:  2017-09-21       Impact factor: 2.692

8.  Ayahuasca's entwined efficacy: An ethnographic study of ritual healing from 'addiction'.

Authors:  Piera Talin; Emilia Sanabria
Journal:  Int J Drug Policy       Date:  2017-04-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.